AM-2201

CAS No. 335161-24-5

AM-2201 ( AM 2201;AM2201 )

Catalog No. M14138 CAS No. 335161-24-5

A synthetic cannabinoid that acts as a potent, nonselective full agonist for the cannabinoid receptor with EC50 of 38 and 58 nM for CB1 and CB2, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AM-2201
  • Note
    Research use only, not for human use.
  • Brief Description
    A synthetic cannabinoid that acts as a potent, nonselective full agonist for the cannabinoid receptor with EC50 of 38 and 58 nM for CB1 and CB2, respectively.
  • Description
    A synthetic cannabinoid that acts as a potent, nonselective full agonist for the cannabinoid receptor with EC50 of 38 and 58 nM for CB1 and CB2, respectively; dose-dependently induces hypothermia and reduces heart rate at doses of 0.3-10 mg/kg in mice.
  • Synonyms
    AM 2201;AM2201
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    335161-24-5
  • Formula Weight
    359.40
  • Molecular Formula
    C24H22FNO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    c1ccc2c(c1)cccc2C(=O)c3cn(c4c3cccc4)CCCCCF
  • Chemical Name
    [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. McQuade D, et al. Eur J Clin Pharmacol. 2013 Mar;69(3):373-6.
2. Sobolevsky T, et al. Drug Test Anal. 2012 Oct;4(10):745-53.
3. Banister SD, et al. ACS Chem Neurosci. 2015 Aug 19;6(8):1445-58.
molnova catalog
related products
  • Fatostatin

    Fatostatin ia an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2.

  • GW405833 hydrochlori...

    A potent, selective cannabinoid receptor CB2 agonist with Ki of 3.6 nM, 1200-fold selectivity over CB1.

  • TM38837

    TM38837 is an antagonist of cannabinoid receptor type 1 (CB1), with potential for the treatment of obesity and type 2 diabetes.